title: The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance.
abstract: The androgen receptor (AR) remains the major oncogenic driver of prostate cancer, as evidenced by the efficacy of androgen deprivation therapy (ADT) in naïve patients, and the continued effectiveness of second generation ADTs in castration resistant disease. However, current ADTs are limited to interfering with AR ligand binding, either through suppression of androgen production or the use of competitive antagonists. Recent studies demonstrate 1) the expression of constitutively active AR splice variants that no longer depend on androgen, and 2) the ability of AR to signal in the cytoplasm independently of its transcriptional activity (non-genomic); thus highlighting the need to consider other ways to target AR. Herein, we review canonical AR signaling, but focus on AR non-genomic signaling, some of its downstream targets and how these effectors contribute to prostate cancer cell behavior. The goals of this review are to 1) re-highlight the continued importance of AR in prostate cancer as the primary driver, 2) discuss the limitations in continuing to use ligand binding as the sole targeting mechanism, 3) discuss the implications of AR non-genomic signaling in cancer progression and therapeutic resistance, and 4) address the need to consider non-genomic AR signaling mechanisms and pathways as a viable targeting strategy in combination with current therapies.
authors.affiliation: The James Buchanan Brady Urological Institute at The Johns Hopkins University School of Medicine Baltimore, MD 21287, United States.
authors.forename: Jelani C
authors.initials: JC
authors.lastname: Zarif
authors.affiliation: Lab of Integrin Signaling and Tumorigenesis, Van Andel Research Institute, Grand Rapids, MI 49503, United States. Electronic address: cindy.miranti@vai.org.
authors.forename: Cindy K
authors.initials: CK
authors.lastname: Miranti
mesh_terms: D059002:Androgen Receptor Antagonists / Q000627:therapeutic use; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism*; D015398:Signal Transduction; D014158:Transcription, Genetic
chemical_list: D059002:Androgen Receptor Antagonists; D011944:Receptors, Androgen
keywords: Androgen receptor; Non-genomic signaling; Prostate cancer; Therapy
references.citation: J Clin Oncol. 2003 Jul 15;21(14):2673-8
references.pmid: 12860943
references.citation: J Cell Biochem. 2006 Oct 1;99(2):362-72
references.pmid: 16619264
references.citation: Oncogene. 2004 Mar 18;23(12):2197-205
references.pmid: 14767470
references.citation: Minerva Urol Nefrol. 2012 Mar;64(1):35-49
references.pmid: 22402316
references.citation: J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):281-6
references.pmid: 17945481
references.citation: J Biol Chem. 2003 Nov 14;278(46):46087-93
references.pmid: 12958311
references.citation: Cell. 1996 Nov 15;87(4):619-28
references.pmid: 8929531
references.citation: PLoS One. 2011;6(11):e27970
references.pmid: 22114732
references.citation: J Biol Chem. 2012 Feb 3;287(6):3777-87
references.pmid: 22174412
references.citation: Endocr Relat Cancer. 2002 Mar;9(1):61-73
references.pmid: 11914183
references.citation: N Engl J Med. 1995 May 25;332(21):1393-8
references.pmid: 7723794
references.citation: J Clin Oncol. 2002 Jul 1;20(13):3001-15
references.pmid: 12089231
references.citation: Exp Physiol. 2013 Jan;98(1):161-71
references.pmid: 22798400
references.citation: Cell. 2009 Jul 23;138(2):245-56
references.pmid: 19632176
references.citation: Cancer Res. 2004 Dec 15;64(24):8867-75
references.pmid: 15604246
references.citation: Biochem J. 2002 Sep 15;366(Pt 3):729-36
references.pmid: 11971763
references.citation: Cancer Res. 2003 Apr 15;63(8):1975-80
references.pmid: 12702591
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6997-7002
references.pmid: 23559371
references.citation: Pharmacol Rev. 2000 Dec;52(4):513-56
references.pmid: 11121509
references.citation: Nature. 1991 Jul 4;352(6330):77-9
references.pmid: 2062380
references.citation: Microsc Res Tech. 1995 Mar 1;30(4):342-50
references.pmid: 7606052
references.citation: BJU Int. 2005 Dec;96(9):1241-6
references.pmid: 16287438
references.citation: Leukemia. 2015 Aug;29(8):1632-6
references.pmid: 25765544
references.citation: Org Lett. 2008 Nov 6;10(21):4947-50
references.pmid: 18834139
references.citation: Genes Cancer. 2011 Jan 1;1(10):1044-1052
references.pmid: 21373373
references.citation: Mol Endocrinol. 2007 Dec;21(12):2855-63
references.pmid: 17636035
references.citation: Steroids. 2010 Aug-Sep;75(8-9):533-8
references.pmid: 19800357
references.citation: Cancer Res. 2011 Mar 15;71(6):2108-17
references.pmid: 21248069
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1643-8
references.pmid: 22307624
references.citation: Endocrinology. 1995 May;136(5):2052-9
references.pmid: 7720654
references.citation: Annu Rev Physiol. 1997;59:365-93
references.pmid: 9074769
references.citation: Cancer Res. 2004 Oct 1;64(19):7156-68
references.pmid: 15466214
references.citation: Lancet. 2010 Apr 24;375(9724):1437-46
references.pmid: 20398925
references.citation: CA Cancer J Clin. 2002 May-Jun;52(3):154-79
references.pmid: 12018929
references.citation: Cancer Res. 2005 Oct 15;65(20):9185-9
references.pmid: 16230377
references.citation: Annu Rev Biochem. 2011;80:437-71
references.pmid: 21548782
references.citation: J Cell Sci. 2006 Feb 15;119(Pt 4):733-43
references.pmid: 16449326
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14783-8
references.pmid: 12415108
references.citation: Oncotarget. 2015 Mar 30;6(9):6862-76
references.pmid: 25730905
references.citation: Nature. 1997 Jun 12;387(6634):733-6
references.pmid: 9192902
references.citation: Endocr Rev. 2007 Dec;28(7):778-808
references.pmid: 17940184
references.citation: J Cell Biol. 2003 May 12;161(3):547-56
references.pmid: 12743104
references.citation: Cancer Res. 2003 Aug 15;63(16):5028-33
references.pmid: 12941830
references.citation: Cancer Res. 2009 Oct 15;69(20):8141-9
references.pmid: 19808968
references.citation: Cancer Res. 2007 Apr 1;67(7):3422-30
references.pmid: 17409453
references.citation: Cancer Cell. 2009 Jul 7;16(1):67-78
references.pmid: 19573813
references.citation: Crit Rev Oncol Hematol. 2005 Dec;56(3):379-96
references.pmid: 16310371
references.citation: Eur Urol. 2013 Feb;63(2):347-53
references.pmid: 22502944
references.citation: Sci Signal. 2014 May 20;7(326):ra48
references.pmid: 24847117
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):265-71
references.pmid: 15663989
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):255-64
references.pmid: 15663988
references.citation: EMBO J. 2000 Oct 16;19(20):5406-17
references.pmid: 11032808
references.citation: Br J Pharmacol. 2013 Oct;170(3):592-601
references.pmid: 23869618
references.citation: J Cell Physiol. 2010 Apr;223(1):14-26
references.pmid: 20049846
references.citation: Cancer Res. 2012 Apr 1;72(7):1878-89
references.pmid: 22350410
references.citation: Nat Genet. 1995 Apr;9(4):401-6
references.pmid: 7795646
references.citation: FEBS Lett. 1990 May 7;264(1):53-5
references.pmid: 2159895
references.citation: J Biol Chem. 2004 Apr 9;279(15):14579-86
references.pmid: 14668339
references.citation: Urol Oncol. 2014 Jan;32(1):53.e15-22
references.pmid: 24239470
references.citation: Clin Cancer Res. 2002 Apr;8(4):1168-71
references.pmid: 11948129
references.citation: Eur Urol. 2015 Jan;67(1):53-60
references.pmid: 24882673
references.citation: J Neurochem. 2005 Sep;94(6):1639-51
references.pmid: 16011741
references.citation: J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):23-30
references.pmid: 11384860
references.citation: CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
references.pmid: 25559415
references.citation: EMBO J. 2011 May 20;30(13):2719-33
references.pmid: 21602788
references.citation: J Biol Chem. 1994 May 6;269(18):13115-23
references.pmid: 8175737
references.citation: Clin Cancer Res. 2010 Sep 1;16(17):4319-24
references.pmid: 20647476
references.citation: Clin Cancer Res. 2002 May;8(5):986-93
references.pmid: 12006510
references.citation: Cancer Res. 2009 Mar 15;69(6):2305-13
references.pmid: 19244107
references.citation: J Biol Chem. 1999 Apr 30;274(18):12827-34
references.pmid: 10212269
references.citation: Oncogene. 1999 Nov 4;18(46):6322-9
references.pmid: 10597231
references.citation: Am J Physiol Cell Physiol. 2006 Jul;291(1):C40-9
references.pmid: 16467405
references.citation: Proteomics. 2001 Oct;1(10):1327-38
references.pmid: 11721644
references.citation: Mol Cell. 2001 Aug;8(2):269-80
references.pmid: 11545730
references.citation: Mol Cell Endocrinol. 1992 Oct;88(1-3):15-22
references.pmid: 1334007
references.citation: Clin Cancer Res. 2004 Dec 15;10(24):8351-6
references.pmid: 15623612
references.citation: Clin Cancer Res. 2005 Jun 15;11(12):4365-71
references.pmid: 15958619
references.citation: Oncotarget. 2015 Apr 30;6(12):10175-94
references.pmid: 25868388
references.citation: J Med Chem. 2012 Jan 12;55(1):503-14
references.pmid: 22148427
references.citation: Front Neuroendocrinol. 2008 May;29(2):169-81
references.pmid: 18093638
references.citation: Biochim Biophys Acta. 2009 Jun;1793(6):1105-9
references.pmid: 19339216
references.citation: Mol Cell Biol. 2011 Feb;31(4):766-82
references.pmid: 21189288
references.citation: Oncogene. 2008 Jun 5;27(25):3596-604
references.pmid: 18223692
references.citation: Clin Cancer Res. 2004 Jan 15;10(2):440-8
references.pmid: 14760063
references.citation: Nat Med. 2004 Jan;10(1):33-9
references.pmid: 14702632
references.citation: J Pharmacol Exp Ther. 2006 Jul;318(1):161-72
references.pmid: 16627750
references.citation: PLoS One. 2011 Apr 28;6(4):e19059
references.pmid: 21552559
references.citation: J Cell Biochem. 2009 Feb 15;106(3):363-71
references.pmid: 19115258
references.citation: J Clin Invest. 1985 Nov;76(5):1899-903
references.pmid: 3902893
references.citation: Oncogene. 2001 Mar 8;20(10):1152-63
references.pmid: 11313859
references.citation: Cell. 2013 Aug 29;154(5):1074-1084
references.pmid: 23993097
references.citation: CA Cancer J Clin. 2005 Sep-Oct;55(5):300-18; quiz 323-5
references.pmid: 16166075
references.citation: Mol Cancer Ther. 2005 Apr;4(4):505-15
references.pmid: 15827323
references.citation: ACS Chem Biol. 2008 Jul 18;3(7):412-8
references.pmid: 18582038
references.citation: Cancer Cell. 2006 Oct;10(4):309-19
references.pmid: 17045208
references.citation: Cancer Res. 2002 Feb 15;62(4):1008-13
references.pmid: 11861374
references.citation: Vitam Horm. 2001;62:199-230
references.pmid: 11345899
references.citation: J Biol Chem. 2002 Aug 23;277(34):30935-41
references.pmid: 12063252
references.citation: Mol Endocrinol. 2010 May;24(5):1007-23
references.pmid: 20207835
references.citation: J Steroid Biochem Mol Biol. 1991;40(1-3):193-7
references.pmid: 1958520
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12182-7
references.pmid: 18723679
references.citation: Cancer Res. 2004 Dec 15;64(24):9209-16
references.pmid: 15604294
references.citation: Nucleic Acids Res. 2007;35(8):2767-76
references.pmid: 17426117
references.citation: Biochem Biophys Res Commun. 1991 Aug 30;179(1):90-6
references.pmid: 1883394
references.citation: EMBO J. 2002 Aug 1;21(15):4037-48
references.pmid: 12145204
references.citation: Int J Oncol. 2012 Nov;41(5):1587-92
references.pmid: 22922989
references.citation: BJU Int. 2009 Jan;103(2):171-7
references.pmid: 18990162
references.citation: Methods Mol Biol. 2011;776:255-73
references.pmid: 21796531
references.citation: Cancer Cell. 2010 Jun 15;17(6):535-46
references.pmid: 20541699
references.citation: Cancer Res. 2014 Jun 15;74(12):3357-68
references.pmid: 24762396
references.citation: Cancer Res. 1994 Jun 1;54(11):2861-4
references.pmid: 8187068
references.citation: Biochemistry. 1992 Mar 3;31(8):2393-9
references.pmid: 1540595
references.citation: Clin Cancer Res. 2013 Mar 15;19(6):1335-9
references.pmid: 23300275
references.citation: J Cell Sci. 2010 Jan 15;123(Pt 2):266-76
references.pmid: 20048343
references.citation: N Engl J Med. 2014 Sep 11;371(11):1028-38
references.pmid: 25184630
references.citation: Clin Cancer Res. 2006 Jul 1;12(13):4072-9
references.pmid: 16818707
references.citation: J Clin Oncol. 2005 Nov 10;23(32):8253-61
references.pmid: 16278481
references.citation: Mol Endocrinol. 2004 May;18(5):1096-108
references.pmid: 14963108
references.citation: Cancer Res. 1985 Aug;45(8):3663-7
references.pmid: 2410099
references.citation: J Clin Invest. 2008 Sep;118(9):3051-64
references.pmid: 18725989
references.citation: Neuroscience. 2007 Oct 12;149(1):155-64
references.pmid: 17870249
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12679-84
references.pmid: 17652515
references.citation: J Natl Cancer Inst. 2002 Mar 6;94(5):384-90
references.pmid: 11880477
references.citation: J Biol Chem. 2003 Oct 31;278(44):42992-3000
references.pmid: 12933816
references.citation: J Cell Biochem. 2006 Oct 1;99(2):392-401
references.pmid: 16639715
references.citation: Mol Endocrinol. 2002 Oct;16(10):2181-7
references.pmid: 12351684
references.citation: Biochem Biophys Res Commun. 1990 Dec 14;173(2):534-40
references.pmid: 2260966
references.citation: Cancer Metastasis Rev. 2003 Dec;22(4):337-58
references.pmid: 12884910
references.citation: Mol Cancer Ther. 2015 Jan;14(1):59-69
references.pmid: 25351916
references.citation: Prostate Cancer Prostatic Dis. 1998 Dec;1(6):307-314
references.pmid: 12496872
references.citation: Science. 2014 Oct 3;346(6205):85-89
references.pmid: 25278611
references.citation: Cell. 2001 Mar 9;104(5):719-30
references.pmid: 11257226
references.citation: Eur Urol. 2013 Aug;64(2):339-40
references.pmid: 23830228
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3320-3
references.pmid: 9096391
references.citation: Cancer Discov. 2013 Sep;3(9):1030-43
references.pmid: 23842682
references.citation: Ann Intern Med. 2012 Jul 17;157(2):120-34
references.pmid: 22801674
references.citation: Eur J Cancer. 2003 Sep;39(13):1927-35
references.pmid: 12932673
references.citation: Cell Cycle. 2007 Jun 1;6(11):1307-13
references.pmid: 17568191
references.citation: J Clin Endocrinol Metab. 2003 Jul;88(7):2972-82
references.pmid: 12843129
references.citation: Cell Growth Differ. 2002 Jan;13(1):1-11
references.pmid: 11801526
references.citation: Res Publ Assoc Res Nerv Ment Dis. 1978;56:255-68
references.pmid: 23572
references.citation: Prostate. 1999 Dec 1;41(4):233-42
references.pmid: 10544296
references.citation: Nat Med. 1999 Mar;5(3):280-5
references.pmid: 10086382
references.citation: Biochem J. 1993 Aug 1;293 ( Pt 3):761-8
references.pmid: 8352744
references.citation: Science. 2005 Oct 28;310(5748):644-8
references.pmid: 16254181
references.citation: Nat Rev Cancer. 2004 Jun;4(6):470-80
references.pmid: 15170449
references.citation: Genes Dev. 2000 Oct 1;14(19):2410-34
references.pmid: 11018010
references.citation: Bioorg Med Chem. 2013 Sep 1;21(17):5261-70
references.pmid: 23845281
references.citation: J Androl. 2006 Sep-Oct;27(5):671-8
references.pmid: 16728719
references.citation: Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16759-65
references.pmid: 20823238
references.citation: Cancer Res. 2013 Jan 15;73(2):483-9
references.pmid: 23117885
references.citation: J Steroid Biochem Mol Biol. 2013 Nov;138:298-306
references.pmid: 23856460
references.citation: J Biol Chem. 2001 Jan 26;276(4):2943-52
references.pmid: 11056175
references.citation: Endocr Rev. 1998 Feb;19(1):3-17
references.pmid: 9494778
references.citation: Cancer Res. 1987 Jan 1;47(1):281-6
references.pmid: 2431765
references.citation: Clin Cancer Res. 2003 Nov 1;9(14):5271-81
references.pmid: 14614009
references.citation: Trends Biochem Sci. 1996 Sep;21(9):327-35
references.pmid: 8870495
references.citation: J Steroid Biochem Mol Biol. 2013 Mar;134:80-91
references.pmid: 23146910
references.citation: Biochem Biophys Res Commun. 2006 Mar 3;341(1):73-81
references.pmid: 16412380
references.citation: Cancer Res. 2004 Aug 1;64(15):5232-6
references.pmid: 15289328
references.citation: EMBO Rep. 2007 Sep;8(9):871-8
references.pmid: 17721441
references.citation: Oncogene. 2012 Nov 8;31(45):4759-67
references.pmid: 22266865
references.citation: Nat Rev Cancer. 2001 Oct;1(1):34-45
references.pmid: 11900250
references.citation: Nat Genet. 2012 May 20;44(6):685-9
references.pmid: 22610119
references.citation: Science. 2009 May 8;324(5928):787-90
references.pmid: 19359544
references.citation: EMBO J. 1998 Apr 1;17(7):2008-18
references.pmid: 9524123
references.citation: Cancer Res. 2008 May 1;68(9):3323-33
references.pmid: 18451159
references.citation: Nucleic Acids Res. 2004 Oct 21;32(18):5693-702
references.pmid: 15498926